Counts describe this library, not the strength of evidence.
How to read this evidence
Comparators explain many apparent contradictions. The 2022 trial tested adding a window to calorie restriction; the 2026 synthesis compared timing and duration across trials. Neither supports assuming the shortest window is best. The corrected PREDIMED report also illustrates why publication history matters.
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Among 143 adolescents aged 10-19 years with diabetes, the mean Eating Attitudes Test score was 16.62 ± 8.30, below the commonly used cutoff, and total score showed no significant difference by glycemic control. The study is a single-hospital snapshot, so it cannot show whether eating attitudes affect blood sugar over time.
A scoping review of 7 studies found that higher Mediterranean diet adherence was generally associated with better female sexual function, for example lower rates of sexual dysfunction in women with type 2 diabetes. The evidence is small and mostly observational or cross-sectional, so it cannot show that the diet improves sexual health.
In 55 adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), 8 weeks of a very-low-calorie ketogenic diet (VLCKD) was followed by improved liver steatosis (CAP p < 0.0001), liver stiffness (p = 0.0005), waist and fat mass. There was no control group, so the changes cannot be separated from weight loss itself or from the passage of time.
In a 6-month trial in which 81 of 106 randomized adults with high cholesterol finished, both a Chilean diet with Chilean hazelnuts (n = 47) and a low-fat diet (n = 34) lowered oxidative damage markers and raised antioxidant enzyme activity in blood immune cells, with no significant differences between groups. The markers were secondary outcomes, so the trial cannot say the hazelnuts added anything.
In two cross-sectional groups of adults with diabetes (3,418 from NHANES and 765 hospitalized Chinese patients), each unit higher HbA1c was associated with higher odds of existing cardiovascular disease (OR 1.097 and OR 1.413). Because both groups were measured at one point in time, the data cannot show whether high HbA1c came before the heart disease.
Pooling 4 studies (1,079 participants), acute hyperglycemic phenotypes were associated with higher short-term all-cause mortality (RR 2.09, 95% CI 1.21-3.64), and pooling 3 studies (679 participants) with invasive mechanical ventilation (RR 3.64, 95% CI 1.74-7.61). The estimates were unadjusted and based on few studies with differing definitions, so they should not be read as causal.
In an online survey of 115 adults, higher olive oil intake was associated with lower anxiety scores (r = -0.249, 95% CI -0.448 to -0.050, p = 0.021), but none of the four primary findings survived correction for multiple testing. The overall Mediterranean diet score showed no clear link with anxiety or depression.
Among 1538 iron workers at Shougang Group, 627 had both arteriosclerosis and knee osteoarthritis; in women, each higher Global Dietary Recommendations (GDR) score point was linked to lower odds of having both (OR 0.75, 95% CI 0.62-0.91). Only 48 women were among the 627 cases and no link appeared in men, so this is a preliminary, exploratory finding.
This review included 23 studies of mobile health (mHealth) nutrition interventions in adults with chronic kidney disease; the 8 eligible for meta-analysis showed no significant effects on biochemical outcomes or interdialytic weight gain in people on dialysis. Improvements reported by pre-post studies, with no control group, cannot be credited to the apps.
Among 247 women aged 19-40 with polyendocrine metabolic ovarian syndrome (PMOS) in Ankara, those with minimal depressive symptoms had higher quality of life than those with mild or moderate-to-severe depression (p < 0.001). The design is cross-sectional with no comparison group, so it shows co-occurrence, not what drives what.
In PREDIMED (7447 high-risk adults), good Mediterranean diet adherence including wine was linked to lower cardiovascular disease (HR 0.55; 95% CI 0.36-0.83) and all-cause mortality (HR 0.67) versus poor adherence, more than without wine (HR 0.84, not significant, and 0.77). Analyses least prone to abstainer bias and interaction tests were not significant, and the younger SUN cohort showed no significant CVD link.
In 88 UK adults with treatment-resistant depression, a ketogenic diet lowered PHQ-9 depression scores by 2.18 points more than a control diet at 6 weeks (95% CI -4.33 to -0.03; P = .05), but the gap was not clear at 12 weeks (P = .10). Both groups improved a lot, the trial was small and short, and the authors say the clinical relevance is uncertain.
In 77 adults with obesity in São Paulo, those in the top third of ultra-processed food intake (over 35.40% of calories) had lower diet quality (37 vs 43.08 overall) and higher binge-eating symptom scores than the lowest third (P = 0.008). With only 77 people at one point in time, direction and cause are unknown.
This narrative review ranks the Mediterranean diet as the best-supported eating pattern for insulin resistance, with consistent HOMA-IR reductions and a 31% lower type 2 diabetes incidence in PREDIMED-Plus. Most studies rely on surrogate insulin-resistance measures and last 26 weeks or less, so long-term benefits for hard outcomes are unproven.
Across 10 studies (1,073 adults with non-dialysis chronic kidney disease), a Mediterranean diet was associated with a modest rise in eGFR (mean difference 2.44 mL/min/1.73 m2, 95% CI 0.16 to 4.72), but heterogeneity was very high (I2 = 90%). The title's claim that it "slows decline" goes beyond a pooled mix of interventional and observational studies.
In a meta-analysis of 8 studies (5 case-control, 3 cohort), high Mediterranean diet adherence was associated with lower odds of multiple sclerosis (fixed-effect OR 0.275, 95% CI 0.11-0.72, p < 0.01), but the cohort studies found no significant relationship. The authors themselves say the evidence is weak because of few studies, retrospective designs, high bias and heterogeneity.
In 193 adults with obesity who had lost weight on a low-calorie diet, exercise plus liraglutide cut stair-climb time by 1.2 s and raised peak oxygen uptake by 3.0 mL/min/kg fat-free mass versus liraglutide alone, and exercise alone gave similar gains. This is a secondary analysis of key secondary endpoints, so it was not the trial's main question.
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.